By week four at 2mg, I had dropped about 9 pounds
Semaglutide, liraglutide, and dulaglutide have demonstrated cardiovascular benefits in clinical trials, with Wegovy (semaglutide 2.4 mg) recently receiving FDA approval for cardiovascular risk reduction in adults with established cardiovascular disease and obesity
While many moms focus solely on the babys healthwhich is understandableyour own recovery is the foundation upon which your babys care is built
Fiber: Constipation is common on GLP-1s, and low fiber is often the culprit
Ozempic is the only FDA-approved oral peptide GLP-1 medication for adults with type 2 diabetes indicated not only to improve blood sugar, along with diet and exercise, but also to reduce the risk of major cardiovascular events (MACE) such as heart attack, stroke, or death in those who are also at high risk for these events